Peptides conjugated to 2-alkoxy-8-oxo-adenine as potential synthetic vaccines triggering TLR7

Bioorg Med Chem Lett. 2019 Jun 1;29(11):1340-1344. doi: 10.1016/j.bmcl.2019.03.048. Epub 2019 Mar 30.

Abstract

Covalent linking of immunogenic oligopeptides with synthetic Toll-like receptor ligands is a useful approach to develop self-adjuvanting vaccines. In particular, small-molecule based agonists of Toll-like receptor 7 (TLR7) that are derived from 8-oxo-adenine core are potentially promising because these chemically robust TLR7 ligands can be connected to peptide T-cell epitopes via straightforward solid-phase peptide synthesis. In this contribution we present the synthesis of a Boc-protected 9-benzyl-2-alkoxy-8-oxo-adenine building block and its application in the online solid phase synthesis of three peptide conjugates that differ in the position of the TLR7 ligand within the peptide. The conjugates are able to induce dendritic cell maturation and T cell proliferation while the position of the ligand impacts T cell proliferation potency.

Keywords: 9-Benzyl-2-butoxy-8-oxo-adenine; Dendritic cells; Synthetic peptide conjugates; T cell proliferation; TLR7 agonist.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives
  • Adenine / chemistry
  • Adenine / pharmacology*
  • Dose-Response Relationship, Drug
  • Humans
  • Ligands
  • Molecular Structure
  • Peptides / chemistry
  • Peptides / pharmacology*
  • Structure-Activity Relationship
  • Toll-Like Receptor 7 / agonists*
  • Toll-Like Receptor 7 / immunology
  • Vaccines, Synthetic / chemistry
  • Vaccines, Synthetic / immunology*

Substances

  • Ligands
  • Peptides
  • TLR7 protein, human
  • Toll-Like Receptor 7
  • Vaccines, Synthetic
  • Adenine